Millipore Sigma Vibrant Logo

567021 Simvastatin, Sodium Salt - Calbiochem

567021
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

Empirical Formula
C₂₅H₃₉O₆ • Na

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
567021-50MG
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Glasflasche 50 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      567021-5MG
      Verfügbarkeit wird abgerufen...
      Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
      Lieferbar 
      Produkt wurde eingestellt
      Begrenzter Lagerbestand
      Bestätigung der Verfügbarkeit erforderlich
        Restmenge: Angebot folgt
          Restmenge: Angebot folgt
          Bitte erfragen
          Kontakt zum Kundenservice
          Contact Customer Service

          Kst.-Ampulle 5 mg
          Preis wird abgerufen...
          Preis nicht abrufbar
          Die Mindestmenge muss ein Vielfaches sein von
          Maximum Quantity is
          Bei Bestätigung Weitere Informationen
          Sie haben () gespart
           
          Bitte erfragen
          Description
          OverviewCarboxylate form of Simvastatin (Cat. No. 567020) that is active in whole cells and in cell-free preparations. Also available as a 10 mM solution in H2O (Cat. No. 567022).
          Catalogue Number567021
          Brand Family Calbiochem®
          SynonymsL-Type Calcium Channel Blocker VI
          References
          ReferencesYada, T., et al. 1999. Br. J. Pharmacol. 126, 1205.
          Clutterbuck, R.D., et al. 1998. Br. J. Haematol. 102, 522.
          Yokoyama, K., et al. 1998. Mol. Biochem. Parasitol. 94, 87.
          Negre-Aminou, P., et al. 1997. Biochim. Biophys. Acta 1345, 259.
          Vrtovsnik, F., et al. 1997. Kidney Int. 52, 1016.
          Keyomarsi, K., et al. 1991. Cancer Res. 51, 3602.
          Product Information
          ATP CompetitiveN
          FormBeige solid
          Hill FormulaC₂₅H₃₉O₆ • Na
          Chemical formulaC₂₅H₃₉O₆ • Na
          Hygroscopic Hygroscopic
          ReversibleN
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary Target3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase
          Purity≥97% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Hygroscopic Hygroscopic
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Bestellnummer GTIN
          567021-50MG 04055977267112
          567021-5MG 07790788051587

          Documentation

          Simvastatin, Sodium Salt - Calbiochem Analysenzertifikate

          TitelChargennummer
          567021

          Literatur

          Übersicht
          Yada, T., et al. 1999. Br. J. Pharmacol. 126, 1205.
          Clutterbuck, R.D., et al. 1998. Br. J. Haematol. 102, 522.
          Yokoyama, K., et al. 1998. Mol. Biochem. Parasitol. 94, 87.
          Negre-Aminou, P., et al. 1997. Biochim. Biophys. Acta 1345, 259.
          Vrtovsnik, F., et al. 1997. Kidney Int. 52, 1016.
          Keyomarsi, K., et al. 1991. Cancer Res. 51, 3602.
          Datenblatt

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision13-October-2015 JSW
          SynonymsL-Type Calcium Channel Blocker VI
          DescriptionCarboxylate form of Simvastatin (Cat. No. 567020) that is active in whole cells and in cell-free assays. A lipophilic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that blocks Ras function through inhibition of farnesylation. Also inhibits glucose-induced Ca2+-signaling and insulin secretion by blocking L-type Ca2+ channels in rat islet β-cells. Inhibits cell proliferation of human smooth muscle cells. Note: This product is supplied in an active form; no treatment with NaOH in ethanol is required for its activation.
          FormBeige solid
          Intert gas (Yes/No) Packaged under inert gas
          Chemical formulaC₂₅H₃₉O₆ • Na
          Structure formulaStructure formula
          Purity≥97% by HPLC
          SolubilityDMSO (100 mg/ml), Ethanol (25 mg/ml), or H₂O (5 mg/ml)
          Storage -20°C
          Hygroscopic
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
          Toxicity Standard Handling
          ReferencesYada, T., et al. 1999. Br. J. Pharmacol. 126, 1205.
          Clutterbuck, R.D., et al. 1998. Br. J. Haematol. 102, 522.
          Yokoyama, K., et al. 1998. Mol. Biochem. Parasitol. 94, 87.
          Negre-Aminou, P., et al. 1997. Biochim. Biophys. Acta 1345, 259.
          Vrtovsnik, F., et al. 1997. Kidney Int. 52, 1016.
          Keyomarsi, K., et al. 1991. Cancer Res. 51, 3602.